SCHEMBL19924420

SCHEMBL19924420

CC(=O)Nc1ccccc1CS

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.55
HPGD P15428 1/20 0.55
MAPK1 P28482 1/20 0.51
TSHR P16473 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HTT P42858 1/20 0.50
CYP2C19 P33261 2/20 0.49
POLB P06746 1/20 0.49
KDM4E B2RXH2 1/20 0.48
LMNA P02545 1/20 0.48
BRD4 O60885 1/20 0.46
HSD17B10 Q99714 2/20 0.45
NAPRT Q6XQN6 1/20 0.45
MAOA P21397 1/20 0.45
TSPO P30536 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
NPC1 O15118 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1644965 0.84 MAPK1 (0.59) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL19900562 0.82 ALDH1A1 (0.46) ALDH1A1HPGDHTTCYP2C19POLB
SCHEMBL30168125 0.82 ALDH1A1 (0.59) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL3150784 0.82 ALDH1A1 (0.59) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL7055476 0.82 ALDH1A1 (0.57) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL19924421 0.82 ALDH1A1 (0.42) ALDH1A1HPGDHTTPOLBL3MBTL1
SCHEMBL6475322 0.81 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL4187803 0.81 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL7236261 0.81 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2
SCHEMBL17123632 0.81 ALDH1A1 (0.55) ALDH1A1HPGDMAPK1TSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018039364-A1 COMPOSITIONS COMPRISING REVERSIBLY MODIFIED OLIGONUCLEOTIDES AND USES THEREOF DICERNA PHARMACEUTICALS, INC. (US) 2018-03-01 WO disclosed